Author

Tal Goldstein

Institutions: Medical University of Vienna, World Economic Forum

Observed institutions: Technion – Israel Institute of Technology, Wiener Krankenanstaltenverbund, Israel National Cyber Directorate, Medical University of Vienna, World Economic Forum

ORCID: 0000-0002-5517-9517

Observed ORCID: 0000-0002-5517-9517

OpenAlex ID: A5111228232

Elinzanetant, a new combined neurokinin-1/-3 receptor antagonist for the treatment of postmenopausal vasomotor symptoms

2024 · Marlene Hager, Tal Goldstein, et al. · Expert Opinion on Pharmacotherapy · 17

Structuring the national cyber defence: in evolution towards a Central Cyber Authority

2017 · Eviatar Matania, Lior Yoffe, et al. · Journal of Cyber Policy · 15

Distribution of prolactin and its correlation with insulin resistance in women with polycystic ovary syndrome

2025 · Stefan Ghobrial, Robert Krysiak, et al. · Frontiers in Endocrinology · 3

Changes in Prolactin and Insulin Resistance in PCOS Patients Undergoing Metformin Treatment: A Retrospective Study

2024 · Tal Goldstein, Johannes Ott, et al. · Journal of Clinical Medicine · 3

Removal of FIGO V and VI fibroids with a combined size greater than 5 cm quadruples spontaneous fecundity relative to myomectomy for those with smaller fibroids

2025 · Magdalena Boegl, Johannes Ott, et al. · Archives of Gynecology and Obstetrics · 2

Anticipatory Governance on Cybersecurity

2025 · Akshay Joshi, Tal Goldstein, et al. · WORLD SCIENTIFIC eBooks · 2

Oblique scattering from non-Hermitian optical waveguides

2023 · Tal Goldstein, Gal Shmuel · Physical Review A · 2

Works count: 7

Citation count: 44

H-index: 3

I10-index: 2